Epiq Capital Group, LLC Alector, Inc. Transaction History
Epiq Capital Group, LLC
- $251 Million
- Q1 2024
Shares
2 transactions
Others Institutions Holding ALEC
# of Institutions
161Shares Held
59.8MCall Options Held
67.8KPut Options Held
200-
Black Rock Inc. New York, NY8.48MShares$38.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.91MShares$22.3 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA4.06MShares$18.4 Million0.7% of portfolio
-
State Street Corp Boston, MA3.92MShares$17.8 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.77MShares$17.1 Million0.75% of portfolio
About Alector, Inc.
- Ticker ALEC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 82,563,904
- Market Cap $375M
- Description
- Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...